about
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective...
Read More
3.58
0.22
(6.55%)
796.9K
XNAS Volume
XNAS 20 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Pyxis Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..